Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria, (RS) 97105-900, Brazil.
Graduated Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), Santa Maria, (RS) 97105-900, Brazil.
Ageing Res Rev. 2024 Aug;99:102374. doi: 10.1016/j.arr.2024.102374. Epub 2024 Jun 25.
Parkinson's disease (PD) is estimated to impact up to 1 % of the global population aged 60 years and older. Among the non-motor manifestations of idiopathic PD, radicular neuropathic pain emerges as a noteworthy concern due to its potential for debility in affected individuals. In, this systematic review and meta-analysis we aimed to evaluate the prevalence of radicular neuropathic pain and thus provide evidence of how this painful symptom affects the lives of patients with idiopathic PD. We registered the research protocol for this study in PROSPERO (CRD42022327220). We searched the Embase, Scopus, and PubMed platforms for studies on PD and neuropathic pain until April 2023. The search yielded 36 articles considered to have a low risk of bias. The prevalence of radicular neuropathic pain in patients with PD was 12.7 %, without a difference when we consider the duration of diagnosis (cut-off < 7 years) or levodopa dosage (cut-off <600 mg/dL). Moreover, there was no variation in the prevalence of radicular neuropathic pain regarding a Hoehn and Yahr stage cut-off of <2.5 or >2.5. Of note, a limited number of patients received pain treatment (21.5 %). We also found that the source of publication bias is the use of the Ford criteria (FC), suggesting that this type of diagnostic criteria may contribute to an underdiagnosis of radicular neuropathic pain in patients with PD. This study underlines the necessity for a more discerning and comprehensive approach to the diagnosis and management of radicular neuropathic pain in patients with idiopathic PD.
帕金森病(PD)估计影响全球多达 1%的 60 岁及以上人群。在特发性 PD 的非运动症状中,神经根性神经病理性疼痛因其可能使受影响的个体衰弱而成为一个值得关注的问题。在本系统评价和荟萃分析中,我们旨在评估神经根性神经病理性疼痛的患病率,从而提供有关这种疼痛症状如何影响特发性 PD 患者生活的证据。我们在 PROSPERO(CRD42022327220)中注册了这项研究的研究方案。我们搜索了 Embase、Scopus 和 PubMed 平台上关于 PD 和神经病理性疼痛的研究,直到 2023 年 4 月。该搜索共产生了 36 篇被认为具有低偏倚风险的文章。PD 患者神经根性神经病理性疼痛的患病率为 12.7%,当我们考虑诊断持续时间(截止值<7 年)或左旋多巴剂量(截止值<600mg/dL)时,没有差异。此外,在 Hoehn 和 Yahr 分期截止值<2.5 或>2.5 时,神经根性神经病理性疼痛的患病率也没有变化。值得注意的是,接受疼痛治疗的患者人数有限(21.5%)。我们还发现,发表偏倚的来源是使用 Ford 标准(FC),这表明这种类型的诊断标准可能导致 PD 患者神经根性神经病理性疼痛的诊断不足。本研究强调了在特发性 PD 患者中,需要更具鉴别力和全面的方法来诊断和管理神经根性神经病理性疼痛。